Α4β7high CD4+ T cells are prone to be infected by HIV‐1 and associated with HIV‐1 disease progression. (15th March 2022)
- Record Type:
- Journal Article
- Title:
- Α4β7high CD4+ T cells are prone to be infected by HIV‐1 and associated with HIV‐1 disease progression. (15th March 2022)
- Main Title:
- Α4β7high CD4+ T cells are prone to be infected by HIV‐1 and associated with HIV‐1 disease progression
- Authors:
- Mijiti, Zilaiguli
Song, Jin‐Wen
Jiao, Yan‐Mei
Gao, Lin
Ma, Hai‐Mei
Guo, Xiao‐Yan
Zhang, Qing
Guo, Yun‐Tian
Ding, Jian‐Bing
Zhang, Shi‐bin
Wang, Fu‐Sheng - Other Names:
- Wang Fu‐Sheng guestEditor.
- Abstract:
- Abstract: Introduction: To investigate the characteristics of β7 high CD4 + T cells during HIV‐1 infection and the relationship between β7 high CD4 + T cells and HIV‐1 disease progress. Methods: This study enrolled 124 HIV‐1‐infected patients, including 80 treatment naïve patients (TNs), 41 patients who underwent antiretroviral therapy (ARTs), and three long‐term no progression patients (LTNPs). Nineteen matched healthy subjects were included as controls (HCs). The characteristics and frequency of β7 high CD4 + T cells were analyzed using flow cytometry. An in vitro culture experiment was used to study HIV‐1 infection of β7 high CD4 + T cells. Real‐time polymerase chain reaction was performed to quantify HIV‐1 DNA and CA‐RNA levels. Results: The frequency of β7 high CD4 + T in the peripheral blood was significantly decreased and negatively correlated with disease progression during chronic HIV‐1 infection. A large proportion of β7 high CD4 + T cells showed Th17 phenotype. Furthermore, β7 high CD4 + T cells were preferentially infected by HIV‐1 in vitro and in vivo. There were no significant differences of HIV‐1 DNA, and CA‐RNA levels between β7 high CD4 + T and β7 low CD4 + T subsets in HIV‐1 infected individuals after antiviral treatment. Conclusion: The β7 high CD4 + T cells were negatively correlated with disease progression during chronic HIV‐1 infection. β7 high CD4 + T cells are susceptible to infection with HIV‐1 and HIV‐1 latent cells.
- Is Part Of:
- HIV medicine. Volume 23(2022)supplement 1
- Journal:
- HIV medicine
- Issue:
- Volume 23(2022)supplement 1
- Issue Display:
- Volume 23, Issue 1 (2022)
- Year:
- 2022
- Volume:
- 23
- Issue:
- 1
- Issue Sort Value:
- 2022-0023-0001-0000
- Page Start:
- 106
- Page End:
- 114
- Publication Date:
- 2022-03-15
- Subjects:
- disease progression -- HIV‐1 -- integrin α4β7 -- β7high CD4+ T cells
HIV infections -- Treatment -- Periodicals
HIV-positive persons -- Periodicals
HIV infections -- Treatment -- Decision making -- Periodicals
616.9792 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=hiv ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-1293 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hiv.13254 ↗
- Languages:
- English
- ISSNs:
- 1464-2662
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4319.045900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21659.xml